drug
ACETAMINOPHEN AND CODEINE PHOSPHATE
updated 5mo agoby Eon Labs Inc
community read0 votes
🐶 often sniffed alongside
top 8- drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN1,124 co-mentions · 562 sources
- tagApproval1,124 co-mentions · 562 sources
- tagSmall Molecule562 co-mentions · 562 sources
- drugcodeine562 co-mentions · 562 sources
- drugPROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE562 co-mentions · 562 sources
- drugPROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE562 co-mentions · 562 sources
- drugPROMETHAZINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE562 co-mentions · 562 sources
- companyStrides Pharma Inc63 co-mentions · 63 sources
all catalysts(0)
nothing on the calendar yet
Trials studying ACETAMINOPHEN AND CODEINE PHOSPHATE
- phase1A Research Study Looking Into How NNC0662-0419 Works With Birth Control Pills and Emptying of the Stomach in Women Not Able to Become Pregnant With Excess Body Weight
- phase3A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain
- phase3A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- phase3Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
- phase2A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- phase3A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- phase3SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM
- phase2A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 6m ago
Found something off?
comments(0)
5-min edit window · permanent after that